Laura Campbell

Laura Campbell

Auto-generated profile, based on publicly available information

Laura Campbell

The Healing Foundation Centre, Faculty of Life Sciences, University of Manchester, Manchester, U.K.

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
LCLaura Campbell
Laura Campbell
CSCharis R. Saville
Charis R. Saville
PMPeter J. Murray
Peter J. Murray
SCSheena M. Cruickshank
Sheena M. Cruickshank
MHMatthew J. Hardman
Matthew J. Hardman
Chronic nonhealing wounds in the elderly population are associated with a prolonged and excessive inflammatory response, which is widely hypothesized to impede healing. Previous studies have linked alterations in local L-arginine metabolism, principally mediated by the enzymes arginase (Arg) and inducible nitric oxide synthase (iNOS), to pathological wound healing. Over subsequent years, interest in Arg/iNOS has focused on the classical versus alternatively activated (M1/M2) macrophage paradigm. Although the role of iNOS during healing has been studied, Arg contribution to healing remains unclear. Here, we report that Arg is dynamically regulated during acute wound healing. Pharmacological inhibition of local Arg activity directly perturbed healing, as did Tie2-cre-mediated deletion of Arg1, revealing the importance of Arg1 during healing. Inhibition or depletion of Arg did not alter alternatively activated macrophage numbers but instead was associated with increased inflammation, including increased influx of iNOS(+) cells and defects in matrix deposition. Finally, we reveal that in preclinical murine models reduced Arg expression directly correlates with delayed healing, and as such may represent an important future therapeutic target.

1 April 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
FSFreya R. Svedberg
Freya R. Svedberg
SBSheila L. Brown
Sheila L. Brown
MKMaria Z. Krauss
Maria Z. Krauss
LCLaura Campbell
Laura Campbell
CSCatherine Sharpe
Catherine Sharpe
AMAndrew S. MacDonald
Andrew S. MacDonald

23 August 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
LCLaura Campbell
Laura Campbell
EEElaine Emmerson
Elaine Emmerson
FDFaith Davies
Faith Davies
SGStephen C. Gilliver
Stephen C. Gilliver
AKAndre Krust
Andre Krust
MHMatthew J. Hardman
Matthew J. Hardman
Post-menopausal women have an increased risk of developing a number of degenerative pathological conditions, linked by the common theme of excessive inflammation. Systemic estrogen replacement (in the form of hormone replacement therapy) is able to accelerate healing of acute cutaneous wounds in elderly females, linked to its potent antiinflammatory activity. However, in contrast to many other age-associated pathologies, the detailed mechanisms through which estrogen modulates skin repair, particularly the cell type–specific role of the two estrogen receptors, ERα and ERβ, has yet to be determined. Here, we use pharmacological activation and genetic deletion to investigate the role of both ERα and ERβ in cutaneous tissue repair. Unexpectedly, we report that exogenous estrogen replacement to ovariectomised mice in the absence of ERβ actually delayed wound healing. Moreover, healing in epidermal-specific ERβ null mice (K14-cre/ERβL2/L2) largely resembled that in global ERβ null mice. Thus, the beneficial effects of estrogen on skin wound healing are mediated by epidermal ERβ, in marked contrast to most other tissues in the body where ERα is predominant. Surprisingly, agonists to both ERα and ERβ are potently antiinflammatory during skin repair, indicating clear uncoupling of inflammation and overall efficiency of repair. Thus, estrogen-mediated antiinflammatory activity is not the principal factor in accelerated wound healing.

1 September 2014 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
LCLaura Campbell
Laura Campbell
EEElaine Emmerson
Elaine Emmerson
HWHelen Williams
Helen Williams
CSCharis R. Saville
Charis R. Saville
AKAndrée Krust
Andrée Krust
MHMatthew J. Hardman
Matthew J. Hardman

1 January 2013 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PBPauline Bannon
Pauline Bannon
SWSally Wood
Sally Wood
TRTerry Restivo
Terry Restivo
LCLaura Campbell
Laura Campbell
MHMatthew J. Hardman
Matthew J. Hardman
KMKimberly A. Mace
Kimberly A. Mace
Summary: Acute inflammation in response to injury is a tightly regulated process by which subsets of leukocytes are recruited to the injured tissue and undergo behavioural changes that are essential for effective tissue repair and regeneration. The diabetic wound environment is characterised by excessive and prolonged inflammation that is linked to poor progression of healing, and, in humans, the development of diabetic foot ulcers. However, the underlying mechanisms contributing to excessive inflammation remain poorly understood. Here we show in a murine model that the diabetic environment induces stable intrinsic changes in haematopoietic cells. These changes lead to a hyper-responsive phenotype to both pro-inflammatory and anti-inflammatory stimuli, producing extreme M1 and M2 polarised cells. During early wound healing, myeloid cells in diabetic mice show hyper-polarisation towards both M1 and M2 phenotypes, whereas, at late stages of healing, when non-diabetic macrophages have transitioned to an M2 phenotype, diabetic wound macrophages continue to display an M1 phenotype. Intriguingly, we show that this population predominantly consists of Gr-1+ CD11b+ CD14+ cells that have been previously reported as 'inflammatory macrophages' recruited to injured tissue in the early stages of wound healing. Finally, we show that this phenomenon is directly relevant to human diabetic ulcers, for which M2 polarisation predicts healing outcome. Thus, treatments focused at targeting this inflammatory cell subset could prove beneficial for pathological tissue repair.

6 June 2016 in Diabetes Care
Verified
Journal Article
Open access
PDF file
RCRyan Thomas Crews
Ryan Thomas Crews
BSBiing-Jiun Shen
Biing-Jiun Shen
LCLaura Campbell
Laura Campbell
PLPeter J. Lamont
Peter J. Lamont
ABAndrew J.M. Boulton
Andrew J.M. Boulton
LVLoretta Vileikyte
Loretta Vileikyte
OBJECTIVE: Studies indicate that off-loading adherence is low in patients with diabetic foot ulcers (DFUs), which may subsequently delay healing. However, there is little empirical evidence for this relationship or the factors that influence adherence. RESEARCH DESIGN AND METHODS: This prospective, multicenter, international study of 79 (46 from the U.K. and 33 the U.S.) persons with type 2 diabetes and plantar DFUs assessed the association between off-loading adherence and DFU healing over a 6-week period. Additionally, potential demographic, disease, and psychological determinants of adherence were examined. DFUs were off-loaded with a removable device (77% a removable cast walker). Off-loading adherence was assessed objectively by activity monitors. Patient-reported measures included Hospital Anxiety and Depression Scale (HADS), Neuropathy and Foot Ulcer Quality of Life (NeuroQoL) instrument, and Revised Illness Perception Questionnaire (IPQ-R). RESULTS: Off-loading adherence was monitored for 35 ± 10 days, and devices were used during 59 ± 22% of subjects' activity. In multivariate analyses, smaller baseline DFU size, U.K. study site, and better off-loading adherence predicted smaller DFU size at 6 weeks (P < 0.05). Better off-loading adherence was, in turn, predicted by larger and more severe baseline DFUs, more severe neuropathy, and NeuroQoL foot pain (P < 0.05). In contrast, greater NeuroQoL postural instability predicted worse off-loading adherence (P < 0.001). HADS and IPQ-R measures were not significantly associated with off-loading adherence. CONCLUSIONS: Off-loading adherence is associated with the amount of DFU healing that occurs, while postural instability is a powerful predictor of nonadherence. Clinicians should take this neuropathic symptom into consideration when selecting an off-loading device, as off-loading–induced postural instability may further contribute to nonadherence.